Blood Bank Of Delmarva, a Division of New York Blood Center, Inc.

Form 483FOIA Uncovered

Newark, Delaware, United StatesFEI 2577603Issued February 11, 2020

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2577603.

Observations2

Issue DateFebruary 11, 2020

StatusNo Warning Letter

Related Inspections8

Establishment Details

Firm: Blood Bank Of Delmarva, a Division of New York Blood Center, Inc.
Location: Newark, Delaware, United States
FEI Number: 2577603
Product Type: Biologics
Issue Date: February 11, 2020
Country: United States

Inspection History, 2008 to 2024

NAI3

VAI5

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Blood Bank Of Delmarva, a Division of New York Blood Center, Inc. FDA Form 483, Newark, Delaware, February 11, 2020